| Pharmaceutical active ingredients: |
| Neostigmine Methylsulfate |
| Available forms, composition and doses of Neostigmine: |
| Injectable; Injection; Neostigmine Methylsulfate 0.5 mg / mlInjectable; Injection; Neostigmine Methylsulfate 1 mg / mlInjectable; Injection; Neostigmine Methylsulfate 2.5 mg / ml |
| Neostigmine medical category: |
| Human:Neuromuscular disorder drugsParasympathomemetic (cholinergic) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N07AA01 - NeostigmineS01EB06 - Neostigmine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sandoz |